Biovie (BIVI) Intangibles (2016 - 2026)
Biovie (BIVI) recorded Intangibles of $6,308 in fiscal Q3 2026 (quarter ended Mar 31, 2026), down 97.3% from $235,685 a year earlier and down 90.1% from the prior quarter.
Powered by 
Analysis
Biovie (BIVI) Intangibles (2016 - 2026) Analysis & Trends
At the end of FY2025 (ended Jun 30, 2025), Biovie reported Intangibles of $178,341, down 56.3% from FY2024.
- Annual Intangibles has declined for nine straight fiscal years, with a five-year compound annual growth rate of -33.0% (FY2020 to FY2025).
- Across earlier fiscal years, Intangibles came in at $407,718 in FY2024 (-36.0%), $637,095 in FY2023 (-26.5%), $866,472 in FY2022 (-20.9%) and $1.1 million in FY2021 (-17.3%).
- The fiscal Q3 2026 figure is the lowest quarterly Intangibles in data going back to fiscal Q4 2016.
- On a year-over-year basis, Intangibles has declined for 24 consecutive quarters, with an average decline of 58.3% over the last eight quarters.
- The year-over-year decline in Intangibles has ranged between 17.3% (fiscal Q4 2021) and 97.3% (fiscal Q3 2026) over the last five years.
- Per Business Quant, the preceding three fiscal quarters came in at $63,653 (Q2 2026), $120,997 (Q1 2026) and $178,341 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Biovie | 11.46 Mn | 11.46 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 6,308.00 |
| Dec 31, 2025 | 63,653.00 |
| Sep 30, 2025 | 120,997.00 |
| Jun 30, 2025 | 178,341.00 |
| Mar 31, 2025 | 235,685.00 |
| Dec 31, 2024 | 293,030.00 |
| Sep 30, 2024 | 350,374.00 |
| Jun 30, 2024 | 407,718.00 |
| Mar 31, 2024 | 465,062.00 |
| Dec 31, 2023 | 522,407.00 |
| Sep 30, 2023 | 579,751.00 |
| Jun 30, 2023 | 637,095.00 |
| Mar 31, 2023 | 694,439.00 |
| Dec 31, 2022 | 751,784.00 |
| Sep 30, 2022 | 809,128.00 |
| Jun 30, 2022 | 866,472.00 |
| Mar 31, 2022 | 923,817.00 |
| Dec 31, 2021 | 981,161.00 |
| Sep 30, 2021 | 1.04 Mn |
| Jun 30, 2021 | 1.10 Mn |
API Access
Biovie Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=BIVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "BIVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=BIVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();